2026-05-19



Regulatory Requirements for Transdermal Patches: FDA and CE Compliance Guide 2026
Introduction
Navigating the regulatory landscape for transdermal patches is essential for market access and compliance. Different regions have specific requirements that manufacturers and brands must understand. This comprehensive guide covers FDA and CE compliance requirements for transdermal patches in 2026.
FDA Requirements for Transdermal Patches

The U.S. Food and Drug Administration (FDA) regulates transdermal patches as drug delivery devices. Key requirements include:
- 510(k) premarket notification: For devices that are substantially equivalent to marketed devices
- Premarket Approval (PMA): For novel devices requiring clinical trials
- Drug Establishment Registration: Required for all facilities manufacturing medical products
- Current Good Manufacturing Practice (cGMP): 21 CFR Part 820 compliance
CE Marking Requirements

| Directive/Regulation | Scope | Key Requirements |
|---|---|---|
| MDR 2017/745 | Medical Devices Regulation | Risk classification, technical documentation |
| ISO 13485 | Quality Management | Quality system requirements |
| ISO 10993 | Biocompatibility | Testing for skin contact safety |
| EN 14683 | Clinical Evaluation | Clinical evidence documentation |
Key Regulatory Steps

- Product classification: Determine regulatory class based on intended use
- Technical documentation: Prepare design history file and design controls
- Risk assessment: Complete risk management per ISO 14971
- Biocompatibility testing: Conduct testing per ISO 10993 series
- Clinical evaluation: Prepare clinical evidence report
- Quality system audit: Pass ISO 13485 certification audit
- Technical file review: Submit to Notified Body for review
Common Compliance Challenges
- Incomplete documentation: Missing required technical files
- Insufficient biocompatibility data: Not meeting ISO 10993 requirements
- Labeling deficiencies: Non-compliant with regional requirements
- Quality system gaps: Not meeting cGMP or ISO 13485 requirements
- Post-market surveillance: Inadequate monitoring systems
Why Choose KONGDY Medical for Regulatory Compliance?
KONGDY Medical ensures regulatory compliance for all markets:
- FDA registered facility: Compliant with U.S. requirements
- CE marked products: Meeting European MDR requirements
- ISO 13485 certified: International quality standards
- 36+ years of experience: Proven regulatory track record
- Comprehensive documentation: Complete technical files
- Regulatory support: Expert guidance for market access
Contact KONGDY Medical today for regulatory compliance support!
